Skip to content
Study details
Enrolling now

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

University of Chicago
NCT IDNCT05166694ClinicalTrials.gov data as of Apr 2026
Target enrollment

1,300

Study length

about 4.9 years

Ages

18+

Locations

1 site in IL

What this study is about

This trial is testing whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications. The PTC will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading it will look for variations in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Drug-Drug Interaction Profile
  • 2.Drug-Gene Interaction Profile
  • 3.Standard of Care

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Rate of Reported Adverse Events as Assessed by Clinical Records

Body systems

Oncology